G9a knockdown, as confirmed by measuring the mRNA levels (Fig 4G), resulted in the reduction in the mRNA levels of CD133 (Fig 4H), Oct4 (Fig 4I), and Nanog (Fig 4J), suggesting that G9a determined the cancer stemness property in A549 cells. The gene discussed is NANOG; the disease is cancer.